DNLI - Leerink likes Acadia Pharma in premarket analyst action September, 13 2019 08:31 AM Denali Therapeutics Inc. Denali Therapeutics (NASDAQ:DNLI) initiated with Buy rating and $35 (84% upside) price target at Nomura Instinet.More news on: Denali Therapeutics Inc., Intuitive Surgical, Inc., ACADIA Pharmaceuticals Inc., Healthcare stocks news, Stocks on the move, , Read more ...